About: http://data.cimple.eu/news-article/80663931e6d476c720cf01a3203236aa21c35f2107fc82eb2f560368

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/80663931e6d476c720cf01a3203236aa21c35f2107fc82eb2f560368 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The European Union's medicines regulator said Friday it had started a "rolling review" of a Covid-19 vaccine developed by German firm CureVac, the first step towards a possible authorisation in the bloc. "Preliminary results from laboratory studies and early clinical studies in adults... suggest the vaccine triggers the production of antibodies and immune cells that target" the coronavirus, the European Medicines Agency (EMA) said in a statement. The rolling review of CureVac's shot will continue "until enough evidence is available for a formal marketing authorisation application", it added. With delays to deliveries of three already-authorised vaccines, the EMA is under pressure from the EU's 27 member states to speed more into service. CureVac's messenger RNA vaccine is currently undergoing large-scale Phase 3 trials, and would be produced by pharma giant Bayer if approved. "If all goes well, EMA authorisation could come in April," Professor Peter Kremsner of the Tuebingen Institute of Tropical Medicine, who is supervising the trial, told German television. The EMA itself said only that authorisation "should take less time than normal" thanks to the rolling review process, which is also being applied to the Novavax and Johnson and Johnson vaccines. bur-smt/abx/tgb/kjl
schema:headline	EU regulator opens review into CureVac's Covid shot
schema:mentions	Novavax Bayer European Medicines Agency Messenger RNA European Union Coronavirus disease Vaccine United States Coronavirus Coronavirus disease 2019 CureVac Monoclonal antibody
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-12 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	86 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software